Clinical trial
Clinical and Biochemical Effects of Macrophage-Targeted Glucocerebrosidase on Neurological Involvement in Neuronopathic Gaucher's Disease
NCT00001289 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical and Biochemical Effects of Macrophage-Targeted Glucocerebrosidase on Neurological Involvement in Neuronopathic Gaucher's Disease
- Lead sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 23, 1991
- Completion date
- March 3, 2008
- Enrollment
- 70
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gaucher's disease